“Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET”, Mediterr J Hematol Infect Dis, vol. 4, no. 1, p. e2012041, Jun. 2012, doi: 10.4084/mjhid.2012.041.